Salient Features :  FDA approved Molnupiravir for treatment of covid infection in early stage of the disease Merck’s clinical trials primarily enrolled people who were infected with the Delta, Mu and Gamma variants of the coronavirus. The antibody treatment approved for treatment may not be effective against the Omicron variant as this variant has several mutations in spike proteins.